AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glisu M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Biomarks Drugs India Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glisu M 1mg/500mg Tablet SR

Diabexe Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic agents. This dual-action medication treats type 2 diabetes in adults by managing blood glucose levels. Diabexe Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. The most frequent adverse reaction is hypoglycemia (low blood sugar). Familiarize yourself with hypoglycemia symptoms (sweating, dizziness, headache, tremors) and appropriate countermeasures. Regular meals and readily available fast-acting glucose sources (e.g., sugary snacks, fruit juice) are essential. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may also occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their doctor before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring, along with potential blood tests to assess blood cell counts and liver function, will be recommended by your physician.

Primary Ingredients of Glisu M 1mg/500mg Tablet SR

There is no text provided to rephrase.

Uses of Glisu M 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glisu M 1mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glisu M 1mg/500mg Tablet SR. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with food.

Common Side effects of Glisu M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glisu M 1mg/500mg Tablet SR:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glisu M 1mg/500mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.

How Glisu M 1mg/500mg Tablet SR works:

Glisu M SR tablets (1mg glimepiride/500mg metformin) combine two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol consumption alongside Glisu M 1mg/500mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glisu M 1mg/500mg tablet might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glisu M tablets (1mg/500mg) are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glisu M 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Glisu M 1mg/500mg SR tablet use. Physician consultation is advised. Kidney function should be regularly monitored during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glisu M 1mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Medical advice is essential. For those with mild to moderate liver disease, initiating therapy with a low Glisu M 1mg/500mg Tablet SR dose is typical; however, it's contraindicated in severe liver disease.

What if you forget to take Glisu M 1mg/500mg Tablet SR :

Should you forget to take a Glisu M 1mg/500mg Tablet SR, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glisu M 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Treatment

FAQs on Glisu M 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glisu M 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Glisu M 1mg/500mg Tablet SR and seek immediate medical attention.
Glisu M 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glisu M 1mg/500mg Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glisu M 1mg/500mg Tablet SR can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental Vitamin B12 intake, at least annually, is recommended by some researchers.
Glisu M 1mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), resulting in symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glisu M 1mg/500mg SR tablets with alcohol is unsafe. Alcohol can exacerbate the medication's effects, potentially causing dangerously low blood sugar (hypoglycemia) and increasing the risk of lactic acidosis.
Glisu M 1mg/500mg Tablet ...
35
MRP 40
12% off